Microbiological Efficacy of Levofloxacin for Treatment of Community-Acquired Pneumonia Due to Chlamydia pneumoniae
AUTOR(ES)
Hammerschlag, Margaret R.
FONTE
American Society for Microbiology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=89886Documentos Relacionados
- Community-acquired Chlamydia pneumoniae pneumonia.
- Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia.
- Moxifloxacin for Community-Acquired Pneumonia
- Liver Involvement with Mycoplasma pneumoniae Community-Acquired Pneumonia
- Microbiologic Efficacy of Azithromycin and Susceptibilities to Azithromycin of Isolates of Chlamydia pneumoniae from Adults and Children with Community-Acquired Pneumonia